European Autism Interventions - A Multicentre Study for Developing New Medications
European Autism Interventions - A Multicentre Study for Developing New Medications is a science project.
0 sources
Summary
European Autism Interventions - A Multicentre Study for Developing New Medications is a science project[1].
Key Facts
- European Autism Interventions - A Multicentre Study for Developing New Medications's instance of is recorded as science project[2].
- European Autism Interventions - A Multicentre Study for Developing New Medications began on April 1, 2012[3].
- European Autism Interventions - A Multicentre Study for Developing New Medications ended on March 31, 2018[4].
- European Autism Interventions - A Multicentre Study for Developing New Medications's short name is recorded as EU-AIMS[5].
- European Autism Interventions - A Multicentre Study for Developing New Medications's budget is recorded as {'unit': 'http://www.wikidata.org/entity/Q4916', 'amount': '+37480613'}[6].
Body
When and Where
European Autism Interventions - A Multicentre Study for Developing New Medications began on April 1, 2012[3]. It ended on March 31, 2018[4].
Context
European Autism Interventions - A Multicentre Study for Developing New Medications's instance of is recorded as science project[2].